Clinical Trials for Bile Duct Cancer

Find clinical trials for bile duct cancer. Discover research opportunities and treatment options in your area.

30 Active Trials Found

Showing 30 trials on this page

Page 1 of 2

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

NCT ID: NCT05000294

This clinical trial is testing a new treatment approach for certain types of cancer that are usually hard to treat with existing immunotherapies, which are therapies designed to help the immune sys...

Recruiting

Phase: PHASE1 Type: interventional Locations: Gainesville, Florida, United States

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

NCT ID: NCT01915225

This clinical trial is focused on collecting tissue samples from patients with certain types of cancer, including colorectal, gastric, bile duct, and pancreas cancers. Researchers need these sample...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

NCT ID: NCT05277766

The PIPAC NAL-IRI study is a clinical trial looking to find the highest safe dose of a treatment called nanoliposomal irinotecan (Nal-IRI) for patients with advanced cancer that has spread within t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ghent, East Flanders, Belgium

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NCT ID: NCT07030140

This clinical trial is studying a new treatment approach for people with a type of bile duct cancer called hilar cholangiocarcinoma, which is located near where the liver’s bile ducts join. The tri...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

NCT ID: NCT07036185

This clinical trial is testing a new treatment called KJ015 for people with certain types of cancers that have a protein called HER2 on their tumor cells. These cancers include stomach, breast, col...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

NCT ID: NCT05346484

This clinical trial is studying a new treatment called CF33-hNIS (VAXINIA), which is an oncolytic virus designed to target and kill cancer cells, particularly in patients with advanced solid tumors...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, Salt Lake City, Utah, United States +11 more

Integrated Cancer Repository for Cancer Research

NCT ID: NCT02012699

The Integrated Cancer Repository for Cancer Research (iCaRe2) is a study designed to gather important information and samples from adults who have been diagnosed with cancer, those at high risk for...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Denver, Colorado, United States +93 more

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

NCT ID: NCT05286814

This clinical trial is studying a new treatment approach for patients with specific types of liver cancer, including metastatic colorectal cancer (which has spread to the liver) and intrahepatic ch...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)

NCT ID: NCT06277531

The clinical trial named ECCBILE is studying a new way to help doctors better understand certain bile duct issues, specifically when they are unsure if the problem is caused by cancer. This trial f...

Recruiting

Type: observational Locations: Beijing, Beijing, China, Beijing, Beijing, China

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

NCT ID: NCT05849480

This clinical trial is investigating a new treatment for biliary tract carcinoma (BTC), a type of cancer affecting the bile ducts. The study is testing a drug called CDX-1140 combined with three ot...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT ID: NCT06048133

This clinical trial, called QUIC, is studying a combination of four medications—gemcitabine, cisplatin, zimberelimab (AB122), and quemliclustat (AB680)—to see how well they work in treating patient...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Brunswick, New Jersey, United States, Madison, Wisconsin, United States +2 more

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

NCT ID: NCT05655949

This clinical trial is exploring a new treatment approach for patients with bile duct cancer that cannot be removed by surgery. The treatment combines three main therapies: Y-90, which is a type of...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

NCT ID: NCT06274879

This clinical trial is investigating the safety of a treatment called biliary radiofrequency ablation (bRFA) for patients with bile duct cancer that cannot be surgically removed. The main goal is t...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Bern, Be, Switzerland

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

NCT ID: NCT06730581

This clinical trial is studying a new treatment called Utidelone capsules for patients with advanced solid tumors, including gastric cancer, ovarian cancer, and bile duct cancer. The goal is to see...

Not yet recruiting

Phase: PHASE2 Type: interventional

Spanish Registry of Digestive Tumours RETUD

NCT ID: NCT06711211

The Spanish Registry of Digestive Tumours (RETUD) is a study looking into the current situation of digestive cancers in Spain, including types like bile duct cancer, liver cancer, colorectal cancer...

Recruiting

Type: observational Locations: Madrid, , Spain

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT ID: NCT04907643

This clinical trial is exploring how virtual reality (VR) can help manage severe abdominal pain in patients with digestive tract cancers. The study aims to find out if using immersive VR—where pati...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT ID: NCT06453590

This clinical trial is looking at different types of metal stents, which are small tubes used to keep blocked bile ducts open for patients with advanced cancers like pancreatic and bile duct cancer...

Recruiting

Phase: NA Type: interventional Locations: Gothenburg, , Sweden, Uppsala, , Sweden +10 more

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

NCT ID: NCT06256055

This clinical trial is studying a new treatment called UCMYM802, which is designed for patients with certain advanced cancers that have a specific protein called mesothelin. This trial is in its fi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

AZD6738 Plus Durvalumab in Biliary Tract Cancer

NCT ID: NCT04298008

This clinical trial is looking at a new treatment option for patients with advanced biliary tract cancer, which includes bile duct and gallbladder cancers. The study will test a combination of two ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions